Annals of hepatology (1117 documentos)


101.-
102.-
103.-
104.-
How to screen NAFLD patients for diabetes?
González Moreno, Emmanuel I1; García Compean, Diego1; González González, José A1; Maldonado Garza, Héctor J1
1Universidad Autónoma de Nuevo León, Hospital Universitario Dr. José Eleuterio González, Monterrey, Nuevo León. México
[Annals of hepatology, México, 2016 Vol. 15 Num. 5 Sep-Oct, Pàg. 801-802]

105.-
106.-
Resistance-associated polymorphisms in Dutch hepatitis C genotype 1a patients with and without HIV infection
Lieveld, Faydra I1; Swaans, Niels2; Newsum, Astrid M3; Ho, Cynthia K.Y3; Schinkel, Janke3; Molenkamp, Richard3; van der Meer, Jan T.M4; Arends, Joop E5; Hoepelman, Andy I.M5; Wensing, Anne M.J6; Siersema, Peter D1; van Erpecum, Karel J1; Boland, Greet J1
1University Medical Center Utrecht, Department of Gastroenterology and Hepatology, Utrecht. Países Bajos; 2University Medical Center Utrecht, Department of Medical Microbiology, Utrecht. Países Bajos; 3Academic Medical Center, Department of Medical Microbiology, Amsterdam. Países Bajos; 4Academic Medical Center, Department of Internal Medicine and Infectious Diseases, Amsterdam. Países Bajos; 5University Medical Center Utrecht, Department of Internal Medicine and Infectious Diseases, Utrecht. Países Bajos; 6University Medical Center Utrecht, Department of Medical Microbiology, Utrecht. Países Bajos
[Annals of hepatology, México, 2016 Vol. 15 Num. 5 Sep-Oct, Pàg. 696-704]

107.-
Risk factors contributing to early infection following transjugular intrahepatic portosystemic shunt in perioperative period
Deng, Peng1; Zhou, Biao1; Li, Xiao2
1Sichuan University, West China Hospital, Chengdu, Sichuan. China; 2National Cancer Center, Cancer Institute and Hospital, Beijing. China
[Annals of hepatology, México, 2016 Vol. 15 Num. 5 Sep-Oct, Pàg. 752-756]

108.-
109.-
110.-
111.-
Alcoholic hepatitis: How far are we and where are we going?
Prado, Verónica1; Caballería, Joan1; Vargas, Víctor2; Bataller, Ramon3; Altamirano, José2
1Hospital Clinic de Barcelona, Unidad de Cuidados Intensivos, Barcelona. España; 2Universidad Autónoma de Barcelona, Hospital Vall d'Hebron, Barcelona. España; 3University of North Carolina, Division of Gastroenterology and Hepatology, Chapel Hill, Carolina del Norte. Estados Unidos de América
[Annals of hepatology, México, 2016 Vol. 15 Num. 4 Jul-Ago, Pàg. 463-473]

112.-
113.-
Association of HLA-DQ and IFNL4 polymorphisms with susceptibility to hepatitis B virus infection and clearance
Fan, Jia-Hao1; Hou, Si-Hui1; Li, Qing-Ling2; Hu, Jun1; Peng, Hong1; Guo, Jin-Jun1
1Chongqing Medical University, The Second Affiliated Hospital, Chongquing, Sichuan. China; 2Chongqing Medical University, Institute of Life Sciences, Chongquing, Sichuan. China
[Annals of hepatology, México, 2016 Vol. 15 Num. 4 Jul-Ago, Pàg. P]

114.-
CUL4B, NEDD4, and UGT1AS involve in the TGF-β signalling in hepatocellular carcinoma
Qu, Zhaowei1; Li, Di2; Xu, Haitao1; Zhang, Rujia2; Li, Bing1; Sun, Chengming1; Dong, Wei1; Zhang, Yubao1
1Harbin Medical University, The Affiliated Tumor Hospital, Harbin, Heilongjiang. China; 2Harbin Medical University, The Second Affiliated Hospital, Harbin, Heilongjiang. China
[Annals of hepatology, México, 2016 Vol. 15 Num. 4 Jul-Ago, Pàg. 568-576]

115.-
116.-
117.-
118.-
Giant cavernous hemangiomata of the liver: Watchful waiting, resection or transplantation?
Mousa, Omar1; Patel, Tushar1
1Mayo Clinic, Department of Transplantation, Jacksonville, Florida. Estados Unidos de América
[Annals of hepatology, México, 2016 Vol. 15 Num. 4 Jul-Ago, Pàg. P]

119.-
Hepatorenal syndrome: Current concepts related to diagnosis and management
Mattos, Angelo Zambam de1; Mattos, Angelo Alves de1; Méndez Sánchez, Nahum2
1Irmandade Santa Casa de Misericordia de Porto Alegre, Hospital Santa Rita, Porto Alegre, Rio Grande do Sul. Brasil; 2Fundación Clínica Médica Sur, Unidad de Investigación Hepática, Ciudad de México. México
[Annals of hepatology, México, 2016 Vol. 15 Num. 4 Jul-Ago, Pàg. 474-481]

120.-